Ticker Details
Caribou Biosciences, Inc.
IPO Date:	July 23, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$192.41M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 4.27%
Avg Daily Range (30 D):	$0.08 | 3.94%
Avg Daily Range (90 D):	$0.07 | 3.59%

Institutional Daily Volume
Avg Daily Volume:	1.19M
Avg Daily Volume (30 D):	1.92M
Avg Daily Volume (90 D):	1.5M

Trade Size
Avg Trade Size (Sh.):	147
Avg Trade Size (Sh.) (30 D):	206
Avg Trade Size (Sh.) (90 D):	196

Institutional Trades
Total Institutional Trades:	522
Avg Institutional Trade:	$1.76M
Avg Institutional Trade (30 D):	$2.8M
Avg Institutional Trade (90 D):	$1.84M
Avg Institutional Trade Volume:	.3M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.91M
Avg Closing Trade (30 D):	$5.63M
Avg Closing Trade (90 D):	$5.63M
Avg Closing Volume:	333.75K

News

Jun 29, 2026 @ 12:00 PM Caribou Biosciences to Participate in the H.C. Wai... Source: Na

Jun 11, 2026 @ 12:00 PM Caribou Biosciences Reports Dose Escalation Durabi... Source: Na

Jan 22, 2026 @ 9:56 AM Genome Editing Market Forecast to Reach $23.6 Bill... Source: Researchandmarkets.Com

Nov 3, 2025 @ 12:00 PM Caribou Biosciences Announces Positive Data from C... Source: Caribou Biosciences

Oct 2, 2025 @ 5:00 PM CRISPR Therapies Clinical Trial Pipeline Shows Pot... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.42	$-.26	$-.28
Diluted EPS	$-1.42	$-.26	$-.28
Revenue	$11.2M	$2.4M	$3.94M
Gross Profit
Net Income / Loss	$-133.22M	$-25.09M	$-26.49M
Operating Income / Loss	$-131.71M	$-26.28M	$-28.45M
Cost of Revenue
Net Cash Flow	$-17.36M	$-.3M	$1.22M
PE Ratio